159 related articles for article (PubMed ID: 31475209)
1. Identification of lung-adenocarcinoma-related long non-coding RNAs by random walking on a competing endogenous RNA network.
Zhang H; Wang Y; Lu J
Ann Transl Med; 2019 Jul; 7(14):339. PubMed ID: 31475209
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
3. Competing endogenous RNA (ceRNA) hypothetic model based on comprehensive analysis of long non-coding RNA expression in lung adenocarcinoma.
Wang X; Su R; Guo Q; Liu J; Ruan B; Wang G
PeerJ; 2019; 7():e8024. PubMed ID: 31720124
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
5. Identification of key genes in lung adenocarcinoma based on a competing endogenous RNA network.
Song Z; Zhang Y; Chen Z; Zhang B
Oncol Lett; 2021 Jan; 21(1):60. PubMed ID: 33281971
[TBL] [Abstract][Full Text] [Related]
6. Identification of a competing endogenous RNA axis "SVIL-AS1/miR-103a/ICE1" associated with chemoresistance in lung adenocarcinoma by comprehensive bioinformatics analysis.
Guo L; Ding L; Tang J
Cancer Med; 2021 Sep; 10(17):6022-6034. PubMed ID: 34264003
[TBL] [Abstract][Full Text] [Related]
7. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma.
Chen R; Xia W; Wang S; Xu Y; Ma Z; Xu W; Zhang E; Wang J; Fang T; Zhang Q; Dong G; Cho WC; Ma PC; Brandi G; Tavolari S; Ujhazy P; Metro G; Popper HH; Yin R; Qiu M; Xu L
Mol Ther Nucleic Acids; 2019 Jun; 16():543-553. PubMed ID: 31071530
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
10. Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma.
Gong Q; Huang X; Chen X; Zhang L; Zhou C; Li S; Song T; Zhuang L
Front Genet; 2023; 14():1083593. PubMed ID: 36999053
[No Abstract] [Full Text] [Related]
11. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
[TBL] [Abstract][Full Text] [Related]
12. A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
Li R; Han K; Xu D; Chen X; Lan S; Liao Y; Sun S; Rao S
Front Genet; 2020; 11():625977. PubMed ID: 33584817
[TBL] [Abstract][Full Text] [Related]
13. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.
Li X; Li B; Ran P; Wang L
Oncol Lett; 2018 Nov; 16(5):5697-5708. PubMed ID: 30344725
[TBL] [Abstract][Full Text] [Related]
14. Immune-related eight-lncRNA signature for improving prognosis prediction of lung adenocarcinoma.
Chen Y; Zhang X; Li J; Zhou M
J Clin Lab Anal; 2021 Nov; 35(11):e24018. PubMed ID: 34550610
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
Liu T; Yang C; Wang W; Liu C
Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Genomic Instability of m
Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ
Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906
[No Abstract] [Full Text] [Related]
17. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis.
Sui Y; Lin G; Zheng Y; Huang W
Eur J Pharmacol; 2019 Sep; 859():172465. PubMed ID: 31211984
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis.
Cai Y; Sheng Z; Chen Y; Wang J
Aging (Albany NY); 2019 May; 11(10):3041-3054. PubMed ID: 31128573
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
20. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T
Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
